On The Future Of Psychiatric Disorders: Part 1 Of Transforming CNS Trials Series

The switch to remote methodologies as a response to COVID-19 has had a profound effect on the conduct of psychiatric disorder trials. Supporting these remote trials requires new tools, sophisticated technology and, most important, deep scientific and clinical expertise.

In this podcast, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase, sits down with WCG President of Patient Advocacy Steve Smith to explore how COVID-19 has forced everyone involved in psychiatric trials to reconsider not only the tools and technology they use, but the entire patient encounter.